These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Farmer T; Reading C Antimicrob Agents Chemother; 1982 Mar; 21(3):506-8. PubMed ID: 6980625 [TBL] [Abstract][Full Text] [Related]
43. Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. Richter SS; Winokur PL; Brueggemann AB; Huynh HK; Rhomberg PR; Wingert EM; Doern GV Antimicrob Agents Chemother; 2000 Feb; 44(2):444-6. PubMed ID: 10639381 [TBL] [Abstract][Full Text] [Related]
44. [Branhamella catarrhalis in infectious pathology of the respiratory tract]. Le Faou A; Rio A Presse Med; 1983 Sep; 12(33):2035-7. PubMed ID: 6226017 [TBL] [Abstract][Full Text] [Related]
45. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children]. Köseoğlu O; Ergin A; Gürkan Aydin N; Hasçelik G Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658 [TBL] [Abstract][Full Text] [Related]
46. [Antibiotic sensitivity of Branhamella catarrhalis isolated from respiratory tract infections]. Nishioka K; Ida S; Takishima T Jpn J Antibiot; 1984 Jul; 37(7):1289-93. PubMed ID: 6567671 [TBL] [Abstract][Full Text] [Related]
47. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics]. Texier-Maugein J; Escoubas J; Fouche J; Mormede M Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431 [TBL] [Abstract][Full Text] [Related]
53. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen. Enright MC; McKenzie H J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030 [TBL] [Abstract][Full Text] [Related]
54. Branhamella catarrhalis pneumonia: report of 4 cases. Yen MY; Tsai IK; Cheng DL; Liu YC; Liu CY; Wang LS Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):610-6. PubMed ID: 2507737 [TBL] [Abstract][Full Text] [Related]
55. Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response. McLeod DT; Ahmad F; Croughan MJ; Calder MA Drugs; 1986; 31 Suppl 3():109-12. PubMed ID: 3732080 [TBL] [Abstract][Full Text] [Related]
56. Increase in bronchopulmonary infection due to branhamella catarrhalis. McLeod DT; Ahmad F; Capewell S; Croughan MJ; Calder MA; Seaton A Br Med J (Clin Res Ed); 1986 Apr; 292(6528):1103-5. PubMed ID: 3084017 [TBL] [Abstract][Full Text] [Related]
57. Enzymatic modification of aminoglycoside antibiotics by Branhamella catarrhalis carrying an R factor. Robledano L; Rivera MJ; Otal I; Gómez-Lus R Drugs Exp Clin Res; 1987; 13(3):137-43. PubMed ID: 3304917 [TBL] [Abstract][Full Text] [Related]
58. Branhamella catarrhalis in acute otitis media. Karma P; Virtanen T; Pukander J; Sipilä M; Luotonen J; Timonen M; Herva E; Grönroos P Acta Otolaryngol; 1985; 99(3-4):285-90. PubMed ID: 3874516 [TBL] [Abstract][Full Text] [Related]